Table 3.
Transport Lag Times of Permeants*
Lag Time (h) | |
---|---|
Bevacizumab | 24 ± 13 |
Ranibizumab | 10 ± 2 |
FITC-BSA | 9.2 ± 6.2 |
FITC-ficoll 70 kDa | 5.0 ± 3.8 |
FITC-dextran 20 kDa | 2.7 ± 1.0 |
FITC-dextran 40 kDa | 2.7 ± 1.0 |
FITC-dextran 150 kDa | 4.4 ± 2.8 |
Data represent the mean and standard deviation of at least three sclera samples for each permeant.